[Diagnosis, evaluation and follow-up of patients with prostatic cancer].
The current diagnostic modalities for diagnosing and evaluating prostate cancer are described. DRE, PSA and TRUS are the three major cornerstones of the diagnostic approach and further evaluation includes bone scans. Lymphnode status can be evaluated only by lymphadenectomy, but is only of interest when curative treatment is considered. Follow-up after both curative intended treatment and hormonal treatment for advanced disease includes regular clinical checkups and evaluation of PSA status. Specific examinations may be considered depending on the symptoms and findings.
Jønler
Morten
M
Regionshospitalet Viborg, Organkirurgisk Afdeling, Urologisk Afsnit. jonler@dadlnet.dk
Pedersen
Knud Venborg
KV
D014408:Biomarkers, Tumor / Q000097:blood; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006801:Humans; D008207:Lymphatic Metastasis / Q000175:diagnosis; D008297:Male; D011467:Prostate / Q000000981:diagnostic imaging / Q000473:pathology; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy; D011470:Prostatic Hyperplasia / Q000175:diagnosis / Q000473:pathology; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000556:secondary / Q000628:therapy; D014463:Ultrasonography
D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen